Tuftsmedicalcenter.org

Center for the Evaluation of Value and Risk in Health at Tufts …

WEB6th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner. The Center for the Evaluation of Value and Risk in Health (CEVR) at …

Actived: 6 days ago

URL: https://cevr.tuftsmedicalcenter.org/

Health system innovation consortium NEWDIGS joins Tufts …

WEBAugust 18, 2022 (BOSTON) – Tufts Medical Center announced today that the NEWDIGS Initiative, a highly respected health system design laboratory, has moved its …

Category: Medical Go Health

SPEC: The Tufts Medical Center Specialty Drug Evidence and …

WEBWelcome! Researchers at the Center for the Evaluation of Value and Risk in Health developed SPEC with the goal of quantifying commercial health plan behavior. …

Category: Health Go Health

National Health Council and Tufts Medical Center Launch New

WEBThe National Health Council (NHC), in partnership with the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center is excited to …

Category: Medical Go Health

How might US health plans cover gene therapies for Sickle Cell …

WEBBy Katherine A. Clifford, MPH, Molly T. Beinfeld, MPH, and James D. Chambers, PhD, MPharm, MSc. December 13, 2023. December 8 th, 2023 was a …

Category: Health Go Health

The much-maligned ‘quality-adjusted life year’ is a vital tool for

WEBHealth policy circles have erupted in debate over a wonky administrative tool: the quality-adjusted life year and similar metrics to value and price drugs and other …

Category: Health Go Health

News & Events

WEB6th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner. The Center for the Evaluation of Value and Risk in Health (CEVR) at …

Category: Health Go Health

Research update: Center for Enhanced Value Assessment (CEVA)

WEBCreation. The Center for Enhanced Value Assessment (CEVA) headquartered within the Center for the Evaluation of Value and Risk in Health (CEVR) …

Category: Health Go Health

Trends and disparities in cardiometabolic health among U.S. adults

WEBWe assessed proportions of adults with optimal cardiometabolic health, based on adiposity, blood glucose, blood lipids, blood pressure, and clinical CVD; and …

Category: Health Go Health

US Commercial Payer Coverage of Dupilumab Varies Widely

WEBClinical criteria embedded in health plans’ coverage policies (2017-2021) Note: The FDA initially approved dupilumab only for adults with atopic dermatitis. The …

Category: Health Go Health

How US commercial health plans are covering semaglutide …

WEBBy Daniel Enright, MS, Molly T. Beinfeld, MPH, and James D. Chambers, PhD, MPharm, MSc. August 17, 2023. Introduction. Two years after its approval, …

Category: Health Go Health

The societal perspective in cost-effectiveness analysis: ICER has …

WEBRemember that ICER defaults to the health system perspective, unless it believes societal costs and effects to be substantial relative to total costs and effects, or if it thinks …

Category: Health Go Health

The Path to Family-Centered Outcomes Research with Tara Lavelle

WEBDate: March 10, 2022 Rachel Breslau (RB): How did you get involved in health economics and outcomes research? Tara Lavelle (TL): I was looking for research jobs after college …

Category: Health Go Health

First look at US commercial health payers’ coverage of Amjevita™ …

WEBSPEC includes information on three principal components: (1) health plan coverage decisions, (2) the evidence health plans cite in their coverage policies, and (3) …

Category: Health Go Health

Variation in payer coverage of mavacamten (Camzyos) for …

WEBHealth plans in SPEC cover roughly 170 million lives, or 70% of the market. SPEC includes 399 drugs manufactured by 105 different pharmaceutical and biotech …

Category: Health Go Health